Tag Archives: buyout

At the beginning of February, we took a look at development stage biotech company Pulmatrix Inc (NASDAQ:PULM) as part of this piece.  At the time, the company had just run up to the tune of 130% on the back of an expedited approval process...

xG Technology Inc (NASDAQ:XGTI) has had a pretty tough start to 2017, with the company down 44% as of Thursday’s close from its January 10 highs. However, as the markets opened on Friday morning in the US, xG picked up some volume, and...

Full-year 2016 financials are hitting press thick and fast in the biotech space right now, and injecting plenty of volatility into the sector. One company that just put out its numbers, but is really moving for a variety of other reasons, is...

Provectus Biopharmaceuticals Inc (OTCMKTS:PVCT) just ran up from $0.019 to $0.026 across a session, logging gains of close to 40%. The gains come on the back of – at first glance, at least – an announcement relating to the appointing of...

Back at the beginning of February, we took a look at Pernix Therapeutics Holdings Inc (NASDAQ:PTX) as part of this piece. The driver behind our turning our attention to Pernix was a then just-reported litigation outcome, detailing the conclusion...

We’ve covered Pernix Therapeutics Holdings Inc (NASDAQ:PTX) on numerous occasions over the last six months. The company has been a tough one to hold from a long-term shareholder perspective, but as we have said in the past, there looks...

Opexa Therapeutics Inc (NASDAQ:OPXA) ran up towards the end of last week on a spike in volume, despite a lack of any clear catalysts. The company has been something of a dead entity for the last couple of months, having put out data from its...

Back on August 3, we made a bold suggestion. In this article, we suggested that Pernix Therapeutics Holdings Inc (NASDAQ:PTX) was in the early stages of dressing itself up for a buyout. Our thesis was simple: the appointment of a new CEO, shortly...

We’ve spent a fair amount of time looking at diagnostics company PositiveID Corp (OTCMKTS:PSID) over the past couple of quarters, and we maintain that, at its current price, the company could be one of the most undervalued stocks on the...

Here at Insider Financial, we’ve been watching Great Basin Scientific Inc (NASDAQ:GBSN) for a long time. We have seen the company rise and fall, and – over the last few quarters at least – collapse into what looked like an irretrievable...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter